IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$0.29
52W Range
$0.27 - $1.40
50D Avg
$0.50
200D Avg
$0.74
Market Cap
$19.24M
Avg Vol (3M)
$487.69K
Beta
2.52
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.